Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions under "Our services"

Valuation: CVRx, Inc.

Market Cap 129M 113M 104M 97.73M 183M 12.22B 186M 1.25B 485M 5.99B 484M 474M 20.83B P/E 2026 *
-2.48x
P/E 2027 * -2.57x
Enterprise Value 154M 136M 125M 117M 219M 14.63B 223M 1.5B 581M 7.18B 580M 567M 24.95B EV / Sales 2026 *
2.37x
EV / Sales 2027 * 2.59x
Free-Float
85.82%
Yield 2026 *
-
Yield 2027 * -
1 day+5.97%
1 week+5.75%
Current month-7.71%
1 month-15.30%
3 months-38.84%
6 months-32.33%
Current year-27.46%
1 week 4.76
Extreme 4.76
5.3
1 month 4.76
Extreme 4.76
6.23
Current year 4.37
Extreme 4.3701
9.84
1 year 4.37
Extreme 4.3701
11.3
3 years 4.3
Extreme 4.2993
33.14
5 years 4.3
Extreme 4.2993
33.14
10 years 4.3
Extreme 4.2993
33.14
Manager TitleAgeSince
Chief Executive Officer 60 12/02/2024
Director of Finance/CFO 43 01/10/2020
Chief Operating Officer 57 11/08/2025
Director TitleAgeSince
Director/Board Member 61 01/10/2008
Director/Board Member 57 01/07/2020
Director/Board Member 52 01/07/2020
Date Insider Type Main position Quantity % Market Cap.
06-01Free

Director

19,902 0.0750%
06-01Free

Director

19,902 0.0750%
06-01
Treo Ventures LLC
OtherCompany 0 0%
Change 5-day change 1-year change 3-year change Capi.($)
+5.97%+5.75%-9.97%-63.86% 129M
+0.45%-0.26%+24.83%-4.93% 12.44B
-0.14%-0.11%+55.06%+26.51% 5.84B
+0.03%-1.88%+5.50%+5.56% 5.47B
-3.38%-6.53% - - 3.99B
-1.43%-9.02%-31.91%+11.53% 3.95B
-0.48%-4.21%-28.71%-27.85% 3.71B
-0.94%+2.11%+58.29%+266.71% 1.88B
+3.82%-19.21%-14.93%-66.17% 1.58B
-0.54%-2.01%+58.19%-7.73% 1.51B
Average +0.44%-3.71%+12.93%+15.53% 4.05B
Weighted average by Cap. -0.15%-2.27%+16.45%+12.12%

Financials

2026 *2027 *
Net sales 65.28M 57.35M 52.85M 49.47M 92.69M 6.18B 94.25M 635M 246M 3.03B 245M 240M 10.55B 76.18M 66.92M 61.66M 57.73M 108M 7.22B 110M 740M 287M 3.54B 286M 280M 12.31B
Net income -52.82M -46.4M -42.76M -40.03M -74.99M -5B -76.26M -513M -199M -2.46B -198M -194M -8.53B -52.14M -45.81M -42.21M -39.51M -74.03M -4.94B -75.28M -507M -196M -2.42B -196M -192M -8.42B
Net Debt 25.51M 22.41M 20.65M 19.33M 36.22M 2.42B 36.83M 248M 95.99M 1.19B 95.77M 93.71M 4.12B 68.44M 60.12M 55.4M 51.86M 97.17M 6.48B 98.8M 665M 258M 3.18B 257M 251M 11.06B
Logo CVRx, Inc.
CVRx, Inc. is a commercial-stage medical device company. The Company is focused on developing, manufacturing and commercializing advanced neuromodulation solutions for patients with cardiovascular diseases. The Company's integrated platform technology, Barostim, is designed to leverage the power of the brain and nervous system to address the imbalance of the autonomic nervous system (ANS), which causes heart failure with reduced ejection fraction (HFrEF) and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy (BAT) by sending imperceptible and persistent electrical pulses to baroreceptors located in the wall of the carotid artery to signal the brain to modulate cardiovascular function. Barostim is a minimally invasive neuromodulation device that consists of two implantable components, an implantable pulse generator (IPG) and a stimulation lead, and is programmed by a wireless clinician-controlled programmer that communicates with the IPG.
Employees
223
Date Price Change Volume
24/06/26 $5.150 +5.97% 310,797
22/06/26 $4.860 -1.82% 434,819
18/06/26 $4.950 +2.48% 293,201
17/06/26 $4.830 -0.82% 241,442
16/06/26 $4.870 -2.21% 101,035
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
4.860USD
Average target price
11.17USD
Spread / Average Target
+129.77%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CVRX Stock
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!